These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 1212067)
1. [Investigation on radiosensitizing and tumor inhibiting actions of the antioxidant MTDQ (6,6'-methylen-bis/2,2,4-trimethyl-1-1,2-dihydroquinolin) (author's transl)]. Bär V; Foris G; Erdélyi V; Pollák Z; Eckhardt S Arch Geschwulstforsch; 1975; 45(5):489-95. PubMed ID: 1212067 [TBL] [Abstract][Full Text] [Related]
2. [Study of the biochemical and radiochemical effects of the agent MTDQ (author's transl]. Pollák ZB; Rodé I; Bär V Strahlentherapie; 1978 Jul; 154(7):499-502. PubMed ID: 209578 [TBL] [Abstract][Full Text] [Related]
3. Biopharmacological investigation of 6,6'methylene-bis/2,2,4-trimethyl-1,2-dihydroquinoline (MTDQ) a radical binding antioxidant of secondary amine type. Bär V; Erdélyi V; Foris G; Pollák Z; Eckhardt S Neoplasma; 1977; 24(3):253-8. PubMed ID: 895935 [TBL] [Abstract][Full Text] [Related]
4. Clinical trials with MTDQ /6,6'-methylene-bis (2,2,4-trimethyl-1,2-dihydroquinoline)/ an antioxidant with radiation sensitizing effect. Erdélyi V; Bär V; Pollák Z; Fodor J; Kralovánszky J; Tóth I; Hindy I; Eckhardt S Strahlentherapie; 1980 Mar; 156(3):198-200. PubMed ID: 6987780 [TBL] [Abstract][Full Text] [Related]
5. [Studies on the combined effects of 5-bromouracil-2-desoxyriboside and x-rays on animal tumors]. Maass H; Grote KH Strahlentherapie; 1967 May; 133(1):102-7. PubMed ID: 5584666 [No Abstract] [Full Text] [Related]
6. Lack of radiosensitization in Lewis lung carcinoma and a murine plasmacytoma by MTDQ and MTDQ-DA. Schlappack OK; Peacock JH; Haslinger RK; Schmidt WF; Eady JJ Strahlenther Onkol; 1988 Nov; 164(11):684-8. PubMed ID: 3201385 [TBL] [Abstract][Full Text] [Related]
7. In vivo tumor inhibitory and radiosensitizing effects of an Indian medicinal plant, Plumbago rosea on experimental mouse tumors. Devi PU; Solomon FE; Sharada AC Indian J Exp Biol; 1994 Aug; 32(8):523-8. PubMed ID: 7959931 [TBL] [Abstract][Full Text] [Related]
8. [Modification of the action of ionizing radiation on cells of transplantable tumors by administering xanthobine]. Volchkov VA; Mikhaĭlova NIa; Klimovich VB Radiobiologiia; 1985; 25(1):112-4. PubMed ID: 3975364 [TBL] [Abstract][Full Text] [Related]
9. Radiosensitizing action of ametohepazon on the irradiated tumor tissues. I. Combined therapy on Yoshida sarcoma. Tobe T; Niibe H; Koike N; Yonome I Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Nov; 27(8):987-94. PubMed ID: 5245252 [No Abstract] [Full Text] [Related]
10. [Ineffectiveness of a drug combination on Yoshida sarcoma and Walker carcinosarcoma 256 of the rat and on Ehrlich carcinoma of the mouse]. Zeller WJ; Wiessler M; Adzersen KH Arzneimittelforschung; 1972 Mar; 22(3):575-7. PubMed ID: 5067931 [No Abstract] [Full Text] [Related]
11. [On the tumor-inhibiting effect of ground substance particles. VII. Effect of glucosamine on the Budapest lymphosarcoma-mouse ascites tumor]. Becker K; Voss H; Lindner J Arch Geschwulstforsch; 1964; 22(4):297-306. PubMed ID: 5896909 [No Abstract] [Full Text] [Related]
12. [Chemotherapy of murine Ehrlich carcinoma and rat Yoshida sarcoma transplanted on hamsters]. Ondrus B; Oravec C; Cambelová J; Mériová M Bratisl Lek Listy; 1970 Sep; 54(3):262-74. PubMed ID: 5475862 [No Abstract] [Full Text] [Related]
13. [Effects of various antitumor agents on intracerebrally inoculated Ehrlich ascites carcinoma in mice (author's transl)]. Zhou JX; He GH; Tao LX; Xu B Zhongguo Yao Li Xue Bao; 1981 Dec; 2(4):256-61. PubMed ID: 6462026 [No Abstract] [Full Text] [Related]
14. [On the electrolyte changes in serum and ascites during cytostatic therapy of transplanted tumors]. Asbach HW Arzneimittelforschung; 1968 Sep; 18(9):1180-2. PubMed ID: 5755934 [No Abstract] [Full Text] [Related]
15. Studies on anti-tumor activity of soedomycin, a new anti-tumor agent. II. Anti-tumor effect on Ehrlich ascites tumor and Yoshida sarcoma, and an outline of clinical application to human patients with carcinoma. Soeda M Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Feb; 26(11):1492-501. PubMed ID: 5231928 [No Abstract] [Full Text] [Related]
17. [Combined use of radiosensitizing and protective agents in experimental radiotherapy]. Magdon E; Schröder E; Iarmonenko SP; Vygodskaia AL; Vinskaia NP Med Radiol (Mosk); 1984 Dec; 29(12):29-32. PubMed ID: 6513748 [TBL] [Abstract][Full Text] [Related]
18. [The radiosensitizing effect of mecytosine on Ehrlich tumor]. Aleksandrov SN; Vershinina SF Vopr Onkol; 1971; 17(9):88-91. PubMed ID: 5138813 [No Abstract] [Full Text] [Related]
19. Inhibition by an antioxidant of the carcinogenic effect of nitrosomorpholine formed in vivo. Börzsönyi M; Torok G; Pinter A; Surján A; Csik M; Bar V IARC Sci Publ; 1982; (41):659-64. PubMed ID: 7141573 [TBL] [Abstract][Full Text] [Related]
20. [Studies on the radiation sensitizing effect of 6-anaurazilribosid depending on the irradiation time in the Ehrlich tumor]. Magdon E; Konopatzky R; Sterescu M Strahlentherapie; 1968 Aug; 136(2):237-40. PubMed ID: 5695894 [No Abstract] [Full Text] [Related] [Next] [New Search]